side effects glp 1 agonist Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists: A State-of-the-Art Narrative Review | Drugs Part 2 of a 3-Part

Some data suggest neuroprotective properties, and there are ongoing randomised trials among patients with neurological and psychiatric disorders (NCT04466345)

Better cardiovascular outcomes of type 2 diabetic patients treated with GLP-1 receptor agonists versus DPP-4 inhibitors in clinical practice

What is Mounjaro and how does it work

We also see a shift away from fast-food restaurants. 1%-to-2% impact on annual calories consumed by 2035 Morgan Stanleys US modeling predicts a 1%-to-2% impact on annual calories consumed by 2035

Additionally, oral semaglutide 50 mg reduced the HbA1c by 2.1% at 68 weeks compared to 1.3% with oral semaglutide 14 mg (Fig